权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Ribosome structure determination from Apicomplexan parasites

顶复门寄生虫的核糖体结构测定

基本信息

批准号：
10726704
负责人：
Melissa Leger-Abraham
金额：
$ 25.43万
依托单位：
HARVARD MEDICAL SCHOOL
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-05-24 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10726704
关键词：
Address Affinity Affinity Chromatography Animal Diseases Animals Anti-Bacterial Agents Antibiotics Antiparasitic Agents Apicomplexa Area Babesia Babesiosis Binding Biology Clinical Complex Cryoelectron Microscopy Cytoplasm Cytoplasmic Structures Cytosol Development Disease Drug resistance Elements Erythrocytes Event Fever Foundations Gene Expression Gene Expression Regulation Geographic Distribution Geography Goals Growth Hemagglutinin Human Immune system Immunocompromised Host Individual Infection Inorganic Phosphate Transporter Laboratories Life Life Cycle Stages Malaria Membrane Methods Mitochondria Molecular Molecular Biology Molecular Structure NMR Spectroscopy Names Organelles Organism Parasites Pathway interactions Pharmaceutical Preparations Plasmodium Plasmodium falciparum Preparation Property Protein Biochemistry Protein Biosynthesis Protocols documentation Public Health Research Proposals Resolution Ribosomal Proteins Ribosomal RNA Ribosomes Structure Symptoms Therapeutic Intervention Thick Tick-Borne Diseases Toxoplasma Toxoplasmosis Translations Vaccines Work X-Ray Crystallography antibiotic design climate change design experience experimental study forest human disease improved novel novel therapeutics particle posttranscriptional rational design structural biology suburb targeted agent targeted treatment tick-borne

项目摘要

PROJECT SUMMARY/ABSTRACT The Apicomplexa phylum contains many parasites that infect and cause disease in humans and animals, including the agents that cause malaria, toxoplasmosis, and babesiosis. Babesia is a tick-borne intracellular parasite that causes severe to fatal diseases, with broadening geographic distribution because of climate change and increasing suburban developments in forested areas. There is no vaccine against human babesiosis, and the current therapies have limited efficacy. Considering the complex life cycle of Babesia species, their survival depends on the precise control of their gene expression, which is mostly regulated post-transcriptionally (e.g., during protein synthesis). Babesia species have a unique, non-photosynthetic organelle named apicoplast, derived from a secondary endosymbiotic event. In addition to having ribosomes in its cytoplasm and mitochondria, the apicoplast contains its own ribosomes. Little is known about the structure of these ribosomes, although they are thought to be highly simplified, with prokaryotic-like components. They are inhibited by antibacterial drugs that have some limited antiparasitic activity. The absence of a molecular structure of any apicoplast ribosomes limits the rational design of antibiotics with improved antiparasitic properties. In the first aim of this research proposal, we will establish a Babesia divergens strain expressing an hemagglutinin (HA)- tagged triose phosphate transporter on the outer membrane of the apicoplast. This strategy will allow the affinity purification of a high-quality organelle preparation, followed by the purification of apicoplast ribosomes. In the second aim, we will define the components of apicoplast ribosomes and determine their structure using cryo- electron microscopy (cryo-EM). Our goal is thus to elucidate the fundamental molecular machinery that apicomplexan parasites use to synthesize proteins in the highly specialized apicoplast organelle. Our work will lay the foundation for studies that interrogate these parasites' gene regulation mechanisms and help inspire the design of better antiparasitic agents.

项目总结/文摘